Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.44 |
| ▸ | CA12 | O43570 | 2/20 | 0.42 |
| ▸ | CA1 | P00915 | 2/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | CA7 | P43166 | 2/20 | 0.42 |
| ▸ | CA9 | Q16790 | 2/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.42 |
| ▸ | XDH | P47989 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
| ▸ | GLA | P06280 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | CASP1 | P29466 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5167967 | 0.88 | MAPT (0.48) | MAPTCA12CA1CA2CA7 | |
| SCHEMBL31405388 | 0.87 | MAPT (0.46) | MAPTCA12CA1CA2CA7 | |
| SCHEMBL2593180 | 0.87 | ERN1 (0.48) | MAPTCA12CA1CA2CA7 | |
| SCHEMBL340676 | 0.86 | TSHR (0.43) | ALDH1A1KMT2AUSP2HSD17B10GAA | |
| SCHEMBL31372250 | 0.85 | KMT2A (0.49) | CA12CA1CA2CA7CA9 | |
| SCHEMBL18360184 | 0.85 | KMT2A (0.49) | CA12CA1CA2CA7CA9 | |
| SCHEMBL339283 | 0.85 | ALDH1A1 (0.49) | MAPTALDH1A1KMT2AKDM4EMEN1 | |
| SCHEMBL339506 | 0.84 | PARP10 (0.50) | MAPTALDH1A1MAPK1KMT2AHTT | |
| SCHEMBL18360185 | 0.83 | HDAC1 (0.42) | MAPTCA1CA2ALDH1A1MAPK1 | |
| SCHEMBL26632400 | 0.82 | MAPT (0.43) | MAPTCA12CA1CA2CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8288576-B2 | Recyclable ruthenium catalysts for metathesis reactions | ZANNAN SCITECH CO., LTD. (CN) | 2012-10-16 | — | — | US | disclosed |
| US-20120016093-A1 | RECYCLABLE RUTHENIUM CATALYSTS FOR METATHESIS REACTIONS | ZANNAN SCITECH CO., LTD. (CN) | 2012-01-19 | — | — | US | disclosed |
| US-8049025-B2 | Recyclable ruthenium catalysts for metathesis reactions | ZANNAN SCITECH CO., LTD. (CN) | 2011-11-01 | — | — | US | disclosed |
| US-20100041844-A1 | RECYCLABLE RUTHENIUM CATALYSTS FOR METATHESIS REACTIONS | ZHENG-YUN JAMES ZHAN (CN) | 2010-02-18 | — | — | US | disclosed |
| US-7632772-B2 | Recyclable ruthenium catalysts for metathesis reactions | Zhan, Zheng-Yun James (CN) | 2009-12-15 | — | — | US | disclosed |
| US-20070043180-A1 | Recyclable ruthenium catalysts for metathesis reactions | ZHENG-YUN JAMES ZHAN (CN) | 2007-02-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120016093-A1 | RECYCLABLE RUTHENIUM CATALYSTS FOR METATHESIS REACTIONS | RPIA, REV1, RCSD1 | MAPT 2838/4885CA12 2792/4885CA1 3352/4885 |
| US-20100041844-A1 | RECYCLABLE RUTHENIUM CATALYSTS FOR METATHESIS REACTIONS | RPIA, REV1, RCSD1 | MAPT 2838/4885CA12 2792/4885CA1 3352/4885 |
| US-20070043180-A1 | Recyclable ruthenium catalysts for metathesis reactions | RPIA, REV1, RCSD1 | MAPT 2838/4885CA12 2792/4885CA1 3352/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.